Today: 9 April 2026
Browse Category

NASDAQ:NOW 24 September 2025 - 5 January 2026

ServiceNow stock today: NOW slips at year-end as CEO McDermott contract filing flags possible co-CEO role

ServiceNow stock today: NOW slips at year-end as CEO McDermott contract filing flags possible co-CEO role

ServiceNow shares closed down 0.7% at $153.19 on Dec. 31, following a 5-for-1 stock split earlier in December. An SEC filing shows CEO Bill McDermott’s contract now runs through 2030, allowing for a possible co-CEO or chairman role. The company also amended its executive severance policy, with enhanced payouts tied to change in control. U.S. markets are closed Jan. 1 for New Year’s Day.
1 January 2026
ServiceNow (NOW) stock slips after hours as CEO contract change nears and $7.75B Armis deal stays in focus

ServiceNow (NOW) stock slips after hours as CEO contract change nears and $7.75B Armis deal stays in focus

ServiceNow shares slipped 0.7% to $153.19 in after-hours trading Wednesday. A regulatory filing showed CEO Bill McDermott’s contract was amended to allow CEO, co-CEO, or chairman roles through at least 2030. Investors are weighing ServiceNow’s planned $7.75 billion cash acquisition of cybersecurity firm Armis, expected to close in the second half of 2026.
ServiceNow stock slips in year-end trade as thin volumes hit growth names — what to watch next

ServiceNow stock slips in year-end trade as thin volumes hit growth names — what to watch next

ServiceNow shares fell 0.3% to $153.81 in thin afternoon trading Wednesday, tracking a broader tech pullback as year-end liquidity dried up. The move followed a 5-for-1 stock split and news of a $7.75 billion deal to acquire cybersecurity firm Armis. Investors are also weighing a CEO contract amendment effective Jan. 1. About 2.8 million shares traded in a narrow range.
31 December 2025
Cloud Computing Stocks Outlook 2026: The Biggest Winners, Risks, and Fresh Analyst Calls as AI Supercharges the Cloud (Dec. 25, 2025)

Cloud Computing Stocks Outlook 2026: The Biggest Winners, Risks, and Fresh Analyst Calls as AI Supercharges the Cloud (Dec. 25, 2025)

Global cloud infrastructure spending reached $102.6 billion in Q3 2025, up 25% from a year earlier, with AWS, Azure, and Google Cloud taking 66% of the market. Tech firms issued $428.3 billion in bonds in 2025 to fund AI and cloud expansion, while credit markets show rising caution. AWS posted 20% revenue growth, Azure 40%, and Google Cloud 36% for the quarter.
Cloud Computing US Stocks Week Ahead: AWS, Microsoft Azure, Oracle, ServiceNow and IBM After a Volatile Dec. 8–14, 2025

Cloud Computing US Stocks Week Ahead: AWS, Microsoft Azure, Oracle, ServiceNow and IBM After a Volatile Dec. 8–14, 2025

Oracle shares fell after its cloud revenue rose 34% to $8 billion but its outlook missed Wall Street targets, raising concerns over rising capital spending. Broadcom warned that a shift toward AI could pressure gross margins despite strong demand, fueling volatility. The Federal Reserve cut rates by 25 basis points, adding to uncertainty for growth stocks. Investors are demanding clearer signs of profitable growth in the cloud sector.
ServiceNow’s AI Revolution: Record Growth, Stock Insights & Bold Moves in 2025

ServiceNow’s AI Revolution: Record Growth, Stock Insights & Bold Moves in 2025

ServiceNow reported Q2 2025 subscription revenue of $3.11 billion, up 22.5% year-over-year. Shares trade in the mid-$900s, down about 12% in 2025, with a market cap near $200 billion. The company launched its “Zurich” AI platform in September and secured a major federal IT deal with the U.S. GSA. Morgan Stanley upgraded the stock to “Overweight” with a $1,250 price target.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop